Skip to content
★ Sign in to follow
GS

Grant Schoenhard

Executive
Filana Therapeutics, Inc.
Total declarations
26
Company
1
▲ Purchases (2 ops.)
€127k
▼ Sales (8 ops.)
€416k

Latest filing published 15 Jul 2014 for FILANA THERAPEUTICS, INC., €429k.

Insider track record

Disclosed buys
2
Disclosed sells
8
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Grant Schoenhard: trading record in brief

All filings by Grant Schoenhard on record concern Filana Therapeutics, Inc. We count 26 filings; the first trade dates from 12 September 2008 and the latest from 11 July 2014.

The open-market side counts 2 purchases for €127k alongside 8 sales for €416k. Taken together, the sales exceed the purchases by €289k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants and 2 option exercises.

The newest entry dates from 15 July 2014: an option exercise of €429k, in Filana Therapeutics, Inc. The clock since the last published purchase (18 March 2010) now reads 6,080 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Grant Schoenhard

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations26 total

25 of 26 declarations